Biomarin Pharmaceutical Inc (BMRN) Insider Trading

Total insider buys:
  • $1,316,196.75
Total insider sells:
  • $342,139,664.94
Most recent insider trade:
  • Nov. 12, 2024
Most active insider trader:
  • Jean Jacques Bienaime
Trader NameDateTitleAmountPriceTypeTotal Value
March 2, 2015CEO5,000$108.44Sell$542,200.00
March 2, 2015SVP23,000$108.31Sell$2,491,130.00
Jan. 9, 2015CEO2,000$94.14Sell$188,280.00
Dec. 24, 2014CEO5,000$88.73Sell$443,650.00
Dec. 10, 2014CEO2,000$95.00Sell$190,000.00
Dec. 4, 2014Director7,500$89.90Sell$674,250.00
Dec. 2, 2014VP11,950$90.91Sell$1,086,374.50
Nov. 25, 2014SVP20,000$89.75Sell$1,795,000.00
Nov. 25, 2014CEO2,000$90.00Sell$180,000.00
Nov. 12, 2014CEO1,000$81.51Sell$81,510.00
Nov. 10, 2014EVP20,000$86.55Sell$1,731,000.00
Nov. 10, 2014CEO4,000$87.00Sell$348,000.00
Nov. 3, 2014CEO3,000$85.33Sell$255,990.00
Nov. 3, 2014SVP47$83.54Sell$3,926.38
Oct. 30, 2014EVP75,425$81.34Sell$6,135,069.50
Oct. 24, 2014CEO2,000$80.00Sell$160,000.00
Sept. 19, 2014SVP17,536$69.75Sell$1,223,136.00
Sept. 2, 2014CFO16,000$69.83Sell$1,117,280.00
Aug. 20, 2014CEO5,000$70.00Sell$350,000.00
Aug. 5, 2014EVP10,000$65.00Sell$650,000.00
Aug. 1, 2014CFO2,229$61.76Sell$137,663.04
July 2, 2014CFO2,229$64.00Sell$142,656.00
June 4, 2014CEO2,000$61.20Sell$122,400.00
May 22, 2014CEO1,000$56.88Sell$56,880.00
May 21, 2014CEO1,545$56.19Sell$86,813.55
May 16, 2014SVP1,004$56.91Sell$57,137.64
May 16, 2014EVP1,864$56.86Sell$105,987.04
May 16, 2014Director1,700$56.87Sell$96,679.00
May 13, 2014EVP1,434$58.23Sell$83,501.82
May 9, 2014EVP3,479$57.91Sell$201,468.89
Feb. 3, 2014EVP10,000$67.70Sell$677,000.00
Dec. 24, 2013CEO10,000$68.71Sell$687,100.00
Dec. 5, 2013CEO5,000$69.70Sell$348,500.00
Oct. 16, 2013CEO2,000$67.73Sell$135,460.00
Oct. 10, 2013CEO3,000$66.76Sell$200,280.00
Sept. 19, 2013EVP10,000$80.19Sell$801,900.00
Sept. 16, 2013CEO2,000$73.08Sell$146,160.00
Sept. 9, 2013EVP20,000$73.00Sell$1,460,000.00
Sept. 5, 2013EVP10,000$70.00Sell$700,000.00
Sept. 4, 2013CFO9,000$69.00Sell$621,000.00
Aug. 15, 2013CEO1,000$64.36Sell$64,360.00
July 1, 2013CFO4,066$59.78Sell$243,065.48
July 1, 2013EVP10,000$60.00Sell$600,000.00
June 3, 2013EVP1,098$58.32Sell$64,035.36
May 23, 2013EVP20,609$66.29Sell$1,366,170.61
May 22, 2013VP3,103$67.12Sell$208,273.36
May 21, 2013CEO2,000$64.14Sell$128,280.00
May 16, 2013CEO12,000$67.90Sell$814,800.00
May 14, 2013SVP20,000$70.34Sell$1,406,800.00
May 14, 2013VP4,947$70.35Sell$348,021.45
  • Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.

  • The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere

  • The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.

  • Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.

  • David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.

  • The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.

  • The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.

  • The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.